Skip to main content
VCbacked
Log inGet Started

Vergent Bioscience

Minneapolis, United States

Vergent Bioscience is a biotech company focusing on the development of tumor-targeted molecular imaging molecules for cancer surgery.

$21.5M raised
Oct 2022
Series B
BiopharmaBiotechnologyHealth CareMedical

Top Investors

Colle Capital PartnersSpring Mountain CapitalWindham Venture PartnersIntuitiveOrlando Health Ventures

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Vergent Bioscience

How much funding has Vergent Bioscience raised?
Vergent Bioscience has raised $21.5M in total funding. The most recent round was Series B. The last funding was announced in October 2022.
Who are Vergent Bioscience's investors?
Vergent Bioscience's investors include Colle Capital Partners, Spring Mountain Capital, Windham Venture Partners, Intuitive, Orlando Health Ventures.
Where is Vergent Bioscience headquartered?
Vergent Bioscience is headquartered in Minneapolis, United States.
What does Vergent Bioscience do?
Vergent Bioscience is a biotech company focusing on the development of tumor-targeted molecular imaging molecules for cancer surgery.
What stage is Vergent Bioscience at?
Vergent Bioscience is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Vergent Bioscience — Funding & Investors." VCBacked, October 4, 2022, https://www.vcbacked.co/company/vergent-bioscience. Accessed July 5, 2026.
APA
VCBacked. (2022). Vergent Bioscience — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/vergent-bioscience
Wikipedia (cite web)
{{cite web |title=Vergent Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/vergent-bioscience |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
Allterum Therapeutics
Houston$1.0M
Epsilogen
London$16.3M
Cairn Therapeutics
Tucson$3.0M
Living In Silico Inc.
Brampton$3K
KuriBio
Berkeley$150K
Systemic Bio
Houston$15.0M